The signals are converted into vital signs like heart rate, respiration rate, body movements, etc. using proprietary cloud-based algorithms
Dozee announced its proprietary contactless vital signs (VS) Measurement technology has received US FDA 510(k) clearance.
Dozee’s proprietary contactless sensor sheet is placed under the patient’s mattress to capture micro-vibrations produced by every heartbeat, respiration cycle, and body movement, using ‘Ballistocardiography’. The Dozee pod placed next to the patient’s bedside converts the vibration data into encrypted digital signals. These signals are converted into vital signs like heart rate, respiration rate, body movements, etc. using proprietary cloud-based algorithms. The vital sign data is presented on a cloud-enabled remote monitoring dashboard to healthcare providers.
“When we started Dozee, our market assessment suggested that India imports 85-90 per cent of the medical devices. Our dream was not just to make India Aatmanirbhar but to elevate India’s position in delivering world-class medical devices and technology globally. We are committed to Made in India, with global standards. USFDA is a gold standard when it comes to medical devices and algorithms. Dozee VS is our flagship contactless vitals technology that has received US FDA Clearance, an important milestone towards our vision #HarBedDozeeBed globally,” said Gaurav Parchani, CTO and Co-Founder of Dozee.
Studies have shown that remote patient monitoring technology reduces the workload on nursing staff for monitoring patients in hospitals and clinics. For Patients, contactless technology improves the in-hospital experience by removing the need for wires, electrodes and cuffs attached to the body. As the paradigm of the healthcare ecosystem evolves, remote patient monitoring will play a crucial role in enhancing the performance, productivity, and profitability of overall healthcare delivery.
